1. 2012 Global and China cardiac stent industry depth research
report
Report Details:
Published:September 2012
No. of Pages: 234
Price: Single User License – US$6500
This report is currently the most professional and the most comprehensive system of the field of
cardiac stents depth market research reports. The report first describes the heart stent
background knowledge related concepts, including heart stents, classification application industry
chain structure, industrial Overview, dynamic analysis, international market and domestic market
dynamics analysis, macroeconomic environment analysis and economic situation in the heart
stent industry affect cardiac stent industry of national policy and planning analysis, heart stent
products, production technology, product cost structure; then detailed statistics of Global and
China major corporate of heart stents capacity production cost selling price profit production value
profit margin data, at the same time statistics these enterprises cardiac stent products customers
applications producing energy market position in enterprise contact way and other information,
then these enterprises related data carried out summary statistics and summary analysis of the
global and Chinese heart stent production energy market share, production market share, the
demand for supply of supply and demand relationship, Import Export consumption statistics, also
introduced global and heart stents 2009-2013 annual production capacity production price cost
profit production value profit margin, after the analysis of cardiac stent industry upstream raw
material downstream customers and products instead of survey analysis, and describes cardiac
stents marketing channels, industry trends, and strategy recommendations, and finally the use of
case mode a the heart stent new project SWOT analysis and investment feasibility analysis.
Overall, this is specifically for the world and the depth of the heart stent industry report, research
centers, with an objective and fair manner depth analyzes the heart stent industry development
trend for customers to conduct competitive analysis, development planning, investment decision-
making provide support and basis for, the support and help of many heart stents industrial chain,
technical personnel and marketing personnel in the course of the operation, to express my
gratitude in this together.
Get your copy of this report @
http://www.reportsnreports.com/reports/195662-2012-global-and-china-cardiac-stent-industry-depth-research-
report.html

2. Major points covered in Table of Contents of this report include
Table of Contents
Chapter heart stents Industry Overview 1
1.1 cardiac stents Definition 1
The 1.2 the heart stents classification and Application 1
1.3 heart stent surgery 3
1.4 heart stent industry chain structure 10
1.5 cardiac stent industry overview 14
Chapter II cardiac stent industry at home and abroad market analysis 21
2.1 cardiac stents Industry international market analysis 21
2.1.1 the heart stents international market development course 21
2.1.2 cardiac stent products and technology developments 22
2.1.3 cardiac stents competitive landscape analysis 28
2.1.4 cardiac stents major international national development situation analysis 33
2.1.5 of heart stents international market trends 37
2.2 cardiac stents Industry domestic market analysis 43
2.2.1 the heart stent domestic market development course 43
Dynamic 43 2.2.2 cardiac stent products and technologies
2.2.3 cardiac stents competitive landscape analysis 47
2.2.4 cardiac stents major domestic regional development situation analysis 50
2.2.5 the heart stent domestic market development trend of 53
2.3 cardiac stent industry domestic and international market comparative analysis of 56
Chapter heart stent development environment Analysis 59
3.1 China's macroeconomic environment analysis 59
3.1.1 Analysis of China's GDP 59
3.1.2 Chinese CPI Analysis 61
3.2 European economic environment analysis and impact 65
3.3 U.S. economic environment analysis and impact 68
3.4 global economic environment analysis and impact 71
Chapter heart stent industry, national policy and planning 72
4.1 National planning policy and development 72
4.1.1 "Twelve Five" period deepening medical and health system planning 72
4.1.2 2012 medical device industry will be affected by the policy support 74
4.1.3 "Twelve Five" period other key health reform 75
4.1.4 "Healthy China 2020" Strategy Research Report "released 75
4.2 sub-industry policy analysis 76
4.2.1 industry authorities and industry regulatory regime 76
4.2.2 national industrial policy 77
4.2.3 The main industry regulatory regulations and standards 77
4.2.4 interventional medical device industry policies and regulations 78
4.3 local policies and development 78
The 4.4 downstream industry policy and demand analysis of 80

3. 4.5 the recent hotspots and the industry impact 81
Chapter heart stent technology, process and cost structure 82
5.1 heart stents 82
5.2 cardiac stent technology process analysis 87
5.3 cardiac stents cost structure analysis 89
Chapter 2009-2013 heart stent production, supply and demand market status and forecast
analysis 90
6.1 2009-2013 the heart stent capacity production statistics 90
Heart stents yield sales market share analysis 6.2 2009-2013 96
2009-2013 demand for heart stents 6.3 Summary 103
6.4 2009-2013 the heart stents supply demand gap in the amount of 106
Cardiac stents Import Export consumption 107 6.5 2009-2013
6.6 2009-2013 the average cost of cardiac stents, price, production value, profit margins 108
Chapter VII of the heart stent core enterprise research 109
7.1 Boston Scientific (Boston Scientific) 109
7.2 Abbott (Abbott Laboratories) - Guidant Guidant 119
7.3 Medtronic (Medtronic) 124
7.4 Johnson & Johnson (J & J Cordis) 129
7.5 Biosensors (Biosensors International) 131
7.6 BIOTRONIK (Biotronik) 136
7.7 Industry poly Medical (OrbusNeich) 142
7.8 Sorin Group (Sorin Group) 149
7.9 Berenger (B.Braun) 153
7.10 Bard (C. R. Bard) - ClearStream 156
7.11 minimally invasive medical (MicroPort) 00853.HK 159
7.12 Dunlop Medical (Lepu) 30003.CH 167
7.13 JW Medical Systems (JW) 174
7.14 Liaoning biological (Yinyi) 178
7.15 Vico medical (Vascore) 181
7.16, Shiner Medical (Sinomed) - Fuji Sunshine 185
7.17 prone (ESSEN) 189
7.18 Jinruikaili 192
71900 Rui Feihong 193
7.20 Suzhou Huan Morning, Medical Technology Co., Ltd. 194
Chapter VIII of the analysis of related industries and 194
8.1 upstream raw material prices and the impact on the industry 194
The 8.2 upstream Equipment market analysis and the impact on the industry 196
The 8.3 downstream demand analysis and impact on the industry 197
8.4 substitute products and impact on the industry 198
Chapter heart stents marketing channels 201
9.1 the heart stents marketing channels Analysis 201
9.2 the heart stents marketing channels management 203

4. 9.3 the heart stents marketing channels to establish a strategy 203
9.4 of heart stents marketing channels trends 204
Chapter heart stent industry trends 206
Cardiac stent industry trends 10.1 2012-2016 206
Market potential forecast 207 10.2 2012-2016
10.3 2012-2016 208 technology research and development trends
10.4 2012-2016 sales channels and sales trends 208
Trends in the development of the competitive landscape in 10.5 2012-2016 209
Import and export trends 210 10.6 2012-2016
Chapter 11 heart stent industry development proposals 211
11.1 Macroeconomic Development Strategies 211
11.2 new enterprises to enter the market strategy 214
The 11.3 new investment recommendations 217
11.4 marketing channel strategy recommendations 219
11.5 competitive environment policy recommendations 220
Chapter 12 heart stents new project investment feasibility analysis of 221
12.1 heart stent project SWOT analysis 221
12.2 new heart stent project feasibility analysis 221
Chapter XIII cardiac stent industry research concluded 222
List of Tables & Figures
Figure heart stents physical map
Table cardiac stents category list
Figure heart stent applications
Figure heart stents Scope
Figure 4 Figure coronary intervention (cardiac stenting) surgical procedure
Figure heart stent surgery diagram 5
Figure angiography Diagram 5
Figure cardiovascular view 6
Figure artery catheter Ways
Figure cardiovascular stenosis and X-ray imaging 7
Figure balloon into the stenosis and balloon dilation 7
Figure holder to enter and release process
Figure contrast agent imaging confirmed coronary treatment effect
Figure heart stent surgery before and after
Figure puncture site local processing, the end of surgery 9
Figure 10 Figure coronary intervention (PCI) is mainly used equipment
Figure medical device industry classification 11
Table medical equipment industry segments and Instrument Description 11
Figure interventional medical devices Type 12
Figure medical devices industry products 13
Figure heart stent sales chain and the distribution of benefits Mode 13
Figure 14 Figure cardiac stent industry chain structure

5. Figure heart stent study technology trends 24
Figure study the course of development of drug-eluting stents 25
Figure 2011 United States and Europe and other regions in the world in the heart stents
production market share Figure 28
2009-2015 global drug eluting stents total stent market share of 29
Figure 2011 Global and U.S. drug-eluting stent market share of 30
Table of foreign brands and characteristics of the coronary stent represents a list of 30
Table coronary stent market competition evolution history 31
Figure 2009 global cardiac stent manufacturers market share distribution of 31
Table 79 global coronary stent manufacturers List 31
Figure global output value of the medical equipment market share in China, the U.S., Japan and
Europe 38
2010-2016 global coronary stent system sales revenue market size ($ millions) 39
Table the size of the global medical device market in 2009-2016 (100 million U.S. dollars) and
interventional medical device market size (million dollars) and accounted for 39
2009-2016 the size of the global medical device market (100 million U.S. dollars) and
interventional medical device market size (million dollars) and its growth rate of 40
Global stent market size (100 million dollars) in 2009-2016, the heart stent market size (million
dollars) and cardiovascular interventional device market size (100 million U.S. dollars) and
accounted for 40
Figure 2009-2016 Global System for cardiac stents market size (million dollars) and
cardiovascular interventional device market size (U.S. $ billion) and growth rate 41
Global stent market size (million dollars) in 2009-2016 and heart stents market size (U.S. $ billion)
and growth rate 41
2009 Global Cardiovascular interventional treatment equipment products classified sales (100
million U.S. dollars) 42
Figure global cardiovascular disease interventional therapy device products output value market
share distribution 42
Figure the first generation arterial stents - bare metal stents (BMS) 44
Figure second-generation arterial stents - drug-eluting stents (DES) 45
The third generation artery stenting Figure - soluble bracket 45
Figure medical equipment sales revenue of Shanghai, Beijing and Shandong, Guangdong,
Jiangsu and other regions nationwide proportion of 51
Figure medical equipment regional distribution of production capacity and a representative
enterprise 51
A list of 52 of the table in Shanghai, China, Beijing, Guangzhou, Shenzhen, Qingdao, Hunan,
Inner Mongolia and other provinces stent reimbursement
Figure domestic health insurance type share distribution of 52
Figure 2000-2012 China PCI surgical cases (million cases) 53
2007-2014 Chinese coronary stent market size (million) 54
2008-2015 the PCI surgery (000 cases) and cardiac stents market size ($ billion) 54
2008-2010 cardiac stent market drug-eluting stents and bare metal stents market share of more

6. than 55
2009 Chinese the heart stents production enterprise market share distribution (by hospital terminal
sales) 55
2009 Chinese the heart stents production enterprise market share distribution (hospital terminal
sales) 56
Table Sino-US similar stent price comparison table 56
Table Sino-US of heart stents producer and Features contrast 57
Table overseas and major types of drug-eluting stents 58
Figure 2006-2015 China medical equipment output value ($ billion) and growth rate 59
Figure 20001-2011 GDP (billion) and growth rate 60
Figure 2007-2011 China medical equipment market size (billion) share of GDP 60
1980-2030 China's urban population size (million) forecast 61
Table 2006-2011 China GDP (billion) and growth rate 61
Figure 2007-2011 China cardiovascular stent market size ($ bn) and growth rate 62
2007-2015 personal medical expenses ($) 62
2007 to 2015, China's per capita health care spending and the national health expenditures
(billion) 63
Figure 2011-2016 China's rate of population growth and aging conditions 64
2000-2011 (cases) and the growth rate of Chinese medical market, the number of PCI operation
64
Figure European prices and gross national product (GDP) declining trend 66
Figure European PMI trend 66
The U.S. core CPI and PCE growth rate comparison 69
Changes in the U.S. private savings rate (left) and changes in U.S. net exports / GDP ratio (right)
70
The proportion of the U.S. public debt and budget deficit to GDP; 70
Table "during the 12th Five-deepening medical and health system planning cum embodiment 72
Table of the world's drug-eluting stent major R & D and product manufacturers (as of 2011) 82
Figure coronary drug-eluting stents process flow diagram 86
Figure drug-eluting stent structure Figure 87
Figure coronary drug-eluting stent system diagram 87
Production flow chart of Figure bare stent 88
Figure 89 Figure stent system production process
2012 heart stent cost structure ($ / month) 90
Table 16 companies around the world in 2009-2013 the production capacity and the total capacity
of the heart stent (ten thousand) List of 90
List 91 Table 2009-2013 16 companies worldwide market share of the production capacity of
cardiac stents
Table 16 companies around the world in 2009-2013 of heart stents production and total production
(ten thousand) List of 91
Table 2009-2013 16 companies around the world the heart stent yield market share List 92
The 2009-2013 global cardiac stents capacity production (million) and growth rate 93

7. Table 2009-2013 the global cardiac stents capacity utilization list of 93
Table 6 companies in China in 2009-2013 cardiac stents capacity and the total capacity (ten
thousand) List 94
List 94 Table 2009-2013 China 6 enterprise market share of the production capacity of cardiac
stents
Table 6 companies in China in 2009-2013 of heart stents production and total output (ten
thousand) List of 94
Table 6 companies in China in 2009-2013 the heart stent yield market share List 94
Figure 2009-2013 China heart stents capacity production (million) and growth rate 95
Table 2009-2013 China heart stent capacity utilization in the list of 95
Figure 16 companies in 2011 the heart stent yield market share Figure 96
Figure 16 companies around the world in 2012 the heart stent yield market share Figure 97
2011 heart stents yield of 6 companies in China market share Figure 97
Figure 6 companies in China in 2012, the heart stents production market share Figure 98
Table 2009-2013 heart stent market mainstream enterprise sales (million) List of 98
2009-2013 Table cardiac stent market mainstream business sales market share List 99
Figure 2011 heart stent market mainstream enterprise sales market share Figure 99
Heart stent market mainstream enterprise sales market share in 2012 Figure 100
2011 Global cardiac stent market drug-eluting stents and bare metal stents market share of more
than 100
The 2011 cardiac stent market drug-eluting stents and bare metal stents market share more than
101
Table 2009-2013 global stent market size (100 million U.S. dollars), the heart stent market size
(100 million U.S. dollars) and accounted for 101
2009-2013 global cardiac stent market size (100 million dollars), cardiovascular interventional
device market size (100 million U.S. dollars) and accounted for 101
2009-2013 global stent market size (100 million dollars), the heart stent market size (U.S. $ billion)
and growth rate 102
The size of the global heart stent market 2009-2013 (billion U.S. dollars), cardiovascular
interventional device market size (U.S. $ billion) and growth rate 102
Table our survey residents incidence of chronic diseases (‰) 103
Table coronary heart disease mortality statistics for urban and rural areas in 2008, respectively
(1/10 000) 103
Table Comparison of coronary heart disease mortality in China and the World 104
Table 2009-2013 the global cardiac stents Price (U.S. $ / month), quantity (million) and the output
value (100 million U.S. dollars) 104
Table 2009-2013 the heart stent Price (U.S. $ / month), quantity (million) and the output value (100
million U.S. dollars) 104
List 104 Table 2009-2013 Global and China cardiac stent market sales (million)
2009-2013 global the PCI surgery Quantity (000 cases), the number of heart stents (million) and
growth rate 105
2009-2013 the number of PCI operation, the use of cardiac stents Number (10,000) and growth

8. rate of 105
Table 2009-2013 the global cardiac stents supply demand gap amount (ten thousand) List 106
Table 2009 China's demand for heart stents distribution 106
Table 2009-2013 the heart stents supply the output gap (ten thousand) List 107
Table 2009-2013 the heart stents supply demand gap (ten thousand) List 107
List 107 Table 2009-2013 China the heart stents production imports export amount of
consumption (million)
Table 2009-2013 the global cardiac stents production (million) (U.S. $ / month) value (million) price
cost profit margin List 108
Table 2009-2013 China heart stent production (million) (U.S. $ / month) value (million) price cost
profit margin list of 108
Table Boston Scientific (Boston Scientific) List of company information (main products, product
applications, origin, production capacity, expansion plans, market position, contact information 13)
109
Figure Boston Scientific (Boston Scientific) involved in the field of medical devices 113
Figure Boston the scientific VeriFLEX ®, Bare-Metal Coronary Stent System (metal bracket) 114
Figure Boston Scientific Drug-Eluting Stents (drug-eluting stents) 115
Figure ION ™ Paclitaxel-Eluting Platinum Chromium Coronary Stent the System 115
Figure Boston Scientific TAXUS ® Express ² ® Coronary Stent System 117
Table 2009-2013 cost price of Boston Scientific cardiac stent (Boston Scientific) Production
(million) profit margin ($ / a) (million U.S. dollars) in output value information List of 118
The 2009-2013 Boston Scientific (Boston Scientific) cardiac stents capacity production (million)
and growth rate 118
Table Abbott (Abbott Laboratories) List of company information (main products, product
applications, origin, production capacity, expansion plans, market position, and contact information
13) 119
Tuya Pei MULTI-LINK 8 LL Coronary Stent System 120
The Tu Yapei XIENCE Everolimus Eluting Coronary Stent System 120
Figure Abbott MULTI-LINK VISION Coronary Stent System 122
Table Abbott (Abbott Laboratories) 2009-2013 the heart stents production (million) cost price profit
(U.S. $ / a) (million U.S. dollars) in output value profit margins Information List of 123
2009-2013 Abbott (Abbott Laboratories) of heart stents capacity production (million) and growth
rate 124
Table Medtronic (Medtronic) List of company information (main products, product applications,
origin, production capacity, expansion plans, market position, contact information 13) 125
Figure Medtronic (Medtronic) medical equipment brand 126
Figure Medtronic (Medtronic) sales in China heart stent the Integrity products list 127
Table 2009-2013 Medtronic cardiac stent (Medtronic) production (million) cost price profit (U.S. $ /
month) output value (million) profit margins List 128
2009-2013 Medtronic (Medtronic) of heart stents capacity production (million) and growth rate 128
Table of Johnson & Johnson (J & J Cordis) List of company information (main products, product
applications, origin, production capacity, expansion plans, market position, contact information 13)

9. 129
Table 2009-2013 Johnson & Johnson (J & J Cordis) the heart stent production (million) cost price
profit (U.S. $ / a) (million U.S. dollars) in output value profit margins List 130
2009-2013 Johnson & Johnson (J & J Cordis) cardiac stents capacity production (million) and
growth rate 130
Table Biosensors (Biosensors International) List of company information (main products, product
applications, origin, production capacity, expansion plans, market position, contact information 13)
131
The heart stents Figure Baisheng Sheng production 133
Figure Baisheng Sheng production of cardiac stents Name Glance 134
Information List 134 Table 2009-2013 Biosensors (Biosensors International) heart stent production
(million) cost price ($ /) output value (million) profit margin
Figure 2009-2013 Biosensors (Biosensors International) of heart stents capacity production
(million) and growth rate 135
Table BIOTRONIK (Biotronik) List of company information (main products, product applications,
origin, production capacity, expansion plans, market position, contact information 13) 136
Figure BIOTRONIK coronary stent intervention system Lekton Motion 138
Figure BIOTRONIK DREAMS - Drug Eluting Absorbable Metal Scaffold 139
Figure BIOTRONIK DREAMS is based on proprietary magnesium technology 140
Figure BIOTRONIK DREAMS - Key Features 140
Figure BIOTRONIK Degradation process for DREAMS 141
Information List 141 Table 2009-2013 BIOTRONIK cardiac stent (Biotronik) (million) production
cost price ($ /) output value (million) profit margin
2009-2013 BIOTRONIK cardiac stents (Biotronik) capacity production (million) and growth rate
142
Table American industry poly Medical Devices (Shenzhen) Co., Ltd. List of company information
(main products, product applications, origin, production capacity, expansion plans, market
position, contact information 13) 142
Figure Industry poly medical device company Global distribution of 145
Figure Industry poly medical device company production of heart stents 146
Figure Industry poly medical CONSTANT ™ Coronary Stent 146
Watch Industry poly Medical the CONSTANT ™ Coronary Stent Order Information 147
Figure Industry poly medical R stent Evolution ™ 2 Coronary Stent System 147
Table 2009-2013 Yeju medical cardiac stents (million) production cost selling price profit (U.S. $ /
month) output value (million) profit margins Information List of 148
2009-2013 industry poly medical cardiac stent production price cost profit production value profit
margin information List of 149
Table Sorin Group (Sorin Group) List of company information (main products, product
applications, origin, production capacity, expansion plans, market position, and contact information
13) 149
Tu Suolin Group (Sorin Group) market share maps 151
Table 2009-2013 Sorin Group (Sorin Group) heart stent production (million) cost price profit (U.S.

10. $ / month) output value (million) Margin Information List 152
2009-2013 Sorin Group (Sorin Group) production capacity of cardiac stents production (million)
and growth rate 152
Table B. Braun (B.Braun) List of company information (main products, product applications, origin,
production capacity, expansion plans, market position, contact information 13) 153
Table B. Braun (B.Braun) Coroflex and Blue coronary stent products Specifications List 154
Germany B. Braun the heart stents production (million) in 2009-2013 cost price (/ a) (million U.S.
dollars) in output value profit margin information List of 155
Germany 2009-2013 Berenger heart stent capacity production (million) and growth rate 155
Table Bard (CR Bard) List of company information (main products, product applications, origin,
production capacity, expansion plans, market position, and contact information 13) 156
Table 2009-2013 Bard (CR Bard) heart stent production (million) cost price profit ($ / a) (million
U.S. dollars) in output value profit margins List 158
2009-2013 Bard (CR Bard) of heart stents capacity production (million) and growth rate 159
Table List of minimally invasive medical devices (Shanghai) Co., Ltd. (main products, product
applications, origin, production capacity, expansion plans, market position, contact information 13)
159
Figure minimally invasive medical Mustang coronary stent (bare metal stents) 161
Figure minimally invasive medical coronary sirolimus-eluting stent system Firebird 162
Figure minimally invasive medical coronary rapamycin-eluting cobalt-based alloy stent system
Firebird2 164
Table minimally invasive medical heart Firebird2 compliance table 164
Table minimally invasive medical cardiac stents Firebird2 diameter (mm), length (mm) list of 165
Table 2009-2013 minimally invasive medical bare metal heart stents production (million) cost price
profit (U.S. $ / month) output value (million) profit margins List 165
Table 2009-2013 minimally invasive medical drug the heart stents production (million) cost price
profit (U.S. $ / month) output value (million) profit margins Information List of 165
Table 2009-2013 minimally invasive medical the heart stents production (million) cost price profit
(U.S. $ / a) (million U.S. dollars) in output value profit margins List 165
2009-2013 minimally invasive medical cardiac stents capacity production (million) and growth rate
166
Medical devices, table Lepu (Beijing) Co., Ltd. Company Information List (main products, product
applications, origin, production capacity, expansion plans, market position, contact information 13)
167
Table Lepu Medical Biguard ™ rapamycin drug-eluting Branch Stent System 168
Figure Lepu medical Partner ® intravascular drug eluting stent system (rapamycin) 169
Figure Lepu medical Nano Plus ™ vascular carrier containing drugs (rapamycin)-eluting stent
system 170
Table the Lok general medical GuReater ™ cobalt-based alloy Jinlei Pa neomycin drug-eluting
stent system (upcoming) 171
Table Lepu medical the heart stents production (million) in 2009-2013 cost price profit ($ / a)
(million U.S. dollars) in output value profit margins List 172

11. Figure Lepu Medical cardiac stents (ten thousand) 2009-2013 capacity production (million) and
growth rate 173
Table JW Medical Products Co., Ltd. List of (main products, product applications, origin,
production capacity, expansion plans, market position, contact information 13) 174
Drug-eluting stent 175 the the Tu Jiwei medical Aikesaier (EXCEL)
Tu Jiwei medical Aikesaier drug-eluting stents (EXCEL) Order Information 176
Table 2009-2013 JW Medical the heart stents production (million) cost price profit (U.S. $ / month)
output value (million) profit margins List 176
2009-2013 JW Medical cardiac stents capacity production (million) and growth rate 177
Table Liaoning Journal of Biomedical Materials R & D Center Co., Ltd. List of company information
(main products, product applications, origin, production capacity, expansion plans, market
position, contact information 13) 178
Figure Liaoning biological drug-eluting coronary metallic stent system (Dalian Yinyi vector
containing drug (paclitaxel)-eluting stent system) 180
Order Information 180 Table the Liaoning biological drug-eluting coronary metallic stent system
Liaoning biological heart stent production (million) in 2009-2013 cost price (/ a) (million U.S.
dollars) in output value profit margin information List of 181
2009-2013 Liaoning the biological heart stent capacity production (million) and growth rate 181
Table Vico Medical Devices (Suzhou) Co., Ltd. List of company information (main products,
product applications, place of origin, capacity expansion plans, market position, contact
information, etc. 13) 182
Figure the Vico medical coronary stent system 182
Tu Weike Medical Polymer-Free stent (Research Products) 183
Table 2009-2013 Vico Medical Devices (Suzhou) Co., Ltd. (ten thousand) heart stent production
cost selling price profit margin information list 184 (/ a) (million U.S. dollars) in output value
2009-2013 Vico medical equipment (Suzhou) Co., Ltd. of heart stents capacity production (million)
and growth rate 184
Table Shiner Medical Science and Technology Co., Ltd. company information list (main products,
product applications, origin, production capacity, expansion plans, market position, contact
information 13) 185
Figure Shiner Medical Science and Technology Co., Ltd. of drug-eluting stents BuMATM 186
Table Shiner the medical BuMATM bracket information table 187
Table Shiner the medical BuMATM bracket Specifications Table 188
Table Shiner the medical BuMATM conveyor system compliance table 188
Table 2009-2013 Shiner medical heart stent production (million) cost price profit (U.S. $ / month)
output value (million) profit margins Information List of 188
2009-2013 Shiner medical cardiac stent production capacity production (million) and growth rate
189
Table prone Technology (Beijing) Co., Ltd. List of company information (main products, product
applications, place of origin, capacity expansion plans, market position, contact information, etc.
13) 189
Figure prone Ericsson (Tivoli) drug-eluting coronary stent 191

12. Table stent production availability of raw materials table 195
Equipment used in the production line of the table bracket and quantity 196
Table 198 three clinical classification and treatment of coronary heart disease
Table of domestic and international marketing of medical devices contrast 205
Table PowerStent drug release cardiac stents Chinese industrial process arrangements 218
SWOT analysis 218 Figure new project
2012 new heart stent Project SWOT analysis of the list of 221
Table cardiac stents New Construction Content List 221
Table cardiac stents new project ROI and feasibility analysis of 222
Contact: sales@reportsandreports.com for more information.